Catherine O'RIORDAN

Person

Bridgewater, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Analytical ultracentrifugation for characterization of recombinant...
- Patent number 12,085,494
- Issue date Sep 10, 2024
- Genzyme Corporation
- Catherine R. O'Riordan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Analytical ultracentrifugation for characterization of recombinant...
- Patent number 12,031,894
- Issue date Jul 9, 2024
- Genzyme Corporation
- Catherine R. O'Riordan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Analytical ultracentrifugation for characterization of recombinant...
- Patent number 12,013,326
- Issue date Jun 18, 2024
- Genzyme Corporation
- Catherine R. O'Riordan
- G01 - MEASURING TESTING
Information Patent Grant
Variant RNAi
- Patent number 11,781,137
- Issue date Oct 10, 2023
- Genzyme Corporation
- Lisa M. Stanek
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for detecting AAV
- Patent number 11,698,377
- Issue date Jul 11, 2023
- Genzyme Corporation
- Xiaoying Jin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Analytical ultracentrifugation for characterization of recombinant...
- Patent number 11,639,887
- Issue date May 2, 2023
- Genzyme Corporation
- Catherine R. O'Riordan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Variant RNAi
- Patent number 11,603,529
- Issue date Mar 14, 2023
- Genzyme Corporation
- Catherine R. O'Riordan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapy for amyotrophic lateral sclerosis and other spinal cor...
- Patent number 11,554,161
- Issue date Jan 17, 2023
- Genzyme Corporation
- James Dodge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapy for retinitis pigmentosa
- Patent number 11,103,598
- Issue date Aug 31, 2021
- Genzyme Corporation
- Catherine O'Riordan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gene therapy for amyotrophic lateral sclerosis and other spinal cor...
- Patent number 10,920,245
- Issue date Feb 16, 2021
- Genzyme Corporation
- Catherine O'Riordan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for treating spinal muscular atrophy
- Patent number 10,821,154
- Issue date Nov 3, 2020
- Genzyme Corporation
- Marco A. Passini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Variant RNAi
- Patent number 10,760,079
- Issue date Sep 1, 2020
- Genzyme Corporation
- Lisa M. Stanek
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapy for spinal cord disorders
- Patent number 10,744,210
- Issue date Aug 18, 2020
- Genzyme Corporation
- James Dodge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Variant RNAi
- Patent number 10,450,563
- Issue date Oct 22, 2019
- Genzyme Corporation
- Lisa M. Stanek
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Analytical ultracentrifugation for characterization of recombinant...
- Patent number 10,429,288
- Issue date Oct 1, 2019
- Genzyme Corporation
- Catherine R. O'Riordan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapy for retinitis pigmentosa
- Patent number 10,383,953
- Issue date Aug 20, 2019
- Genzyme Corporation
- Catherine O'Riordan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods to produce rod-derived cone viability factor (RDCVF)
- Patent number 10,035,829
- Issue date Jul 31, 2018
- Genzyme Corporation
- Catherine R. O'Riordan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Gene therapy for amyotrophic lateral sclerosis and other spinal cor...
- Patent number 9,890,394
- Issue date Feb 13, 2018
- Genzyme Corporation
- Catherine O'Riordan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods to produce rod-derived cone viability factor (RdCVF)
- Patent number 9,567,382
- Issue date Feb 14, 2017
- Genzyme Corporation
- Catherine R. O'Riordan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Gene therapy for amyotrophic lateral sclerosis and other spinal cor...
- Patent number 9,034,836
- Issue date May 19, 2015
- Genzyme Corporation
- James Dodge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Purification of adenovirus and AAV
- Patent number 7,579,181
- Issue date Aug 25, 2009
- Genzyme Corporation
- Catherine E. O'Riordan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Purification of adenovirus and AAV
- Patent number 7,015,026
- Issue date Mar 21, 2006
- Genzyme Corporation
- Catherine E. O'Riordan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Tresyl-monomethoxypolyethylene glycol-modified viruses having viral...
- Patent number 6,569,426
- Issue date May 27, 2003
- Genzyme Corporation
- Alan E. Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acid delivery vehicles
- Patent number 6,287,857
- Issue date Sep 11, 2001
- Genzyme Corporation
- Catherine R. O'Riordan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chromatographic purification of adeno-associated virus (AAV)
- Patent number 6,143,548
- Issue date Nov 7, 2000
- Genzyme Corporation
- Catherine E. O'Riordan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for purifying cystic fibrosis transmembrane conductance reg...
- Patent number 5,939,536
- Issue date Aug 17, 1999
- Genzyme Corporation
- Catherine R. O'Riordan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
VARIANT RNAi
- Publication number 20240182896
- Publication date Jun 6, 2024
- Genzyme Corporation
- Lisa M. STANEK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANALYTICAL ULTRACENTRIFUGATION FOR CHARACTERIZATION OF RECOMBINANT...
- Publication number 20240085301
- Publication date Mar 14, 2024
- Genzyme Corporation
- Catherine R. O'RIORDAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANALYTICAL ULTRACENTRIFUGATION FOR CHARACTERIZATION OF RECOMBINANT...
- Publication number 20240077402
- Publication date Mar 7, 2024
- Genzyme Corporation
- Catherine R. O'RIORDAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compositions and Methods for Treating Spinal Muscular Atrophy
- Publication number 20240000886
- Publication date Jan 4, 2024
- Genzyme Corporation
- Marco A. PASSINI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED GENE THERAPY FOR DM-1 MYOTONIC DYSTROPHY
- Publication number 20230365968
- Publication date Nov 16, 2023
- Genzyme Corporation
- Seng Cheng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL COR...
- Publication number 20230364200
- Publication date Nov 16, 2023
- Genzyme Corporation
- James Dodge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS TO PRODUCE ROD-DERIVED CONE VIABILITY FACTOR (RDCVF)
- Publication number 20230322873
- Publication date Oct 12, 2023
- Genzyme Corporation
- Catherine R. O’RIORDAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANALYTICAL ULTRACENTRIFUGATION FOR CHARACTERIZATION OF RECOMBINANT...
- Publication number 20230288308
- Publication date Sep 14, 2023
- Genzyme Corporation
- Catherine R. O'RIORDAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPY FOR RETINITIS PIGMENTOSA
- Publication number 20220054657
- Publication date Feb 24, 2022
- Genzyme Corporation
- Catherine O'RIORDAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED ADENO-ASSOCIATED VIRAL CAPSID PROTEINS FOR OCULAR GENE THE...
- Publication number 20210261625
- Publication date Aug 26, 2021
- Amy Frederick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING SPINAL MUSCULAR ATROPHY
- Publication number 20210121523
- Publication date Apr 29, 2021
- Genzyme Corporation
- Marco A. PASSINI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VARIANT RNAi
- Publication number 20210047641
- Publication date Feb 18, 2021
- Genzyme Corporation
- Lisa M. STANEK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR DETECTING AAV
- Publication number 20210041451
- Publication date Feb 11, 2021
- Genzyme Corporation
- Xiaoying JIN
- G01 - MEASURING TESTING
Information Patent Application
GENE THERAPY FOR SPINAL CORD DISORDERS
- Publication number 20210008227
- Publication date Jan 14, 2021
- Genzyme Corporation
- James DODGE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANALYTICAL ULTRACENTRIFUGATION FOR CHARACTERIZATION OF RECOMBINANT...
- Publication number 20200225139
- Publication date Jul 16, 2020
- Genzyme Corporation
- Catherine R. O'RIORDAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VARIANT RNAi
- Publication number 20200216848
- Publication date Jul 9, 2020
- Genzyme Corporation
- Catherine R. O'RIORDAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VARIANT RNAi
- Publication number 20200109401
- Publication date Apr 9, 2020
- Genzyme Corporation
- Lisa M. STANEK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL COR...
- Publication number 20200101138
- Publication date Apr 2, 2020
- Genzyme Corporation
- James Dodge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENE THERAPY FOR RETINITIS PIGMENTOSA
- Publication number 20200046851
- Publication date Feb 13, 2020
- Genzyme Corporation
- Catherine O'RIORDAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS TO PRODUCE ROD-DERIVED CONE VIABILITY FACTOR (RDCVF)
- Publication number 20190055293
- Publication date Feb 21, 2019
- Genzyme Corporation
- Catherine R. O'Riordan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL COR...
- Publication number 20180230490
- Publication date Aug 16, 2018
- Genzyme Corporation
- Catherine O'RIORDAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANALYTICAL ULTRACENTRIFUGATION FOR CHARACTERIZATION OF RECOMBINANT...
- Publication number 20180180525
- Publication date Jun 28, 2018
- Genzyme Corporation
- Catherine R. O'RIORDAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VARIANT RNAi
- Publication number 20180023082
- Publication date Jan 25, 2018
- Genzyme Corporation
- Lisa M. STANEK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS TO PRODUCE ROD-DERIVED CONE VIABILITY FACTOR (RDCVF)
- Publication number 20170369541
- Publication date Dec 28, 2017
- Genzyme Corporation
- Catherine R. O'Riordan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GENE THERAPY FOR RETINITIS PIGMENTOSA
- Publication number 20170173183
- Publication date Jun 22, 2017
- Genzyme Corporation
- Catherine O'RIORDAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING SPINAL MUSCULAR ATROPHY
- Publication number 20160074474
- Publication date Mar 17, 2016
- Genzyme Corporation
- Marco A. PASSINI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL COR...
- Publication number 20160067312
- Publication date Mar 10, 2016
- Genzyme Corporation
- James Dodge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS TO PRODUCE ROD-DERIVED CONE VIABILITY FACTOR (RDCVF)
- Publication number 20110034546
- Publication date Feb 10, 2011
- Genzyme Corporation
- Catherine R. O'Riordan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PURIFICATION OF ADENOVIRUS AND AAV
- Publication number 20100279385
- Publication date Nov 4, 2010
- Catherine E. O'Riordan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL COR...
- Publication number 20100267812
- Publication date Oct 21, 2010
- Genzyme Corporation
- James Dodge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Catherine O'RIORDAN

Person

Patents Grantslast 30 patents

Analytical ultracentrifugation for characterization of recombinant...

Analytical ultracentrifugation for characterization of recombinant...

Analytical ultracentrifugation for characterization of recombinant...

Variant RNAi

Methods for detecting AAV

Analytical ultracentrifugation for characterization of recombinant...

Variant RNAi

Gene therapy for amyotrophic lateral sclerosis and other spinal cor...

Gene therapy for retinitis pigmentosa

Gene therapy for amyotrophic lateral sclerosis and other spinal cor...

Compositions and methods for treating spinal muscular atrophy

Variant RNAi

Gene therapy for spinal cord disorders

Variant RNAi

Analytical ultracentrifugation for characterization of recombinant...

Gene therapy for retinitis pigmentosa

Methods to produce rod-derived cone viability factor (RDCVF)

Gene therapy for amyotrophic lateral sclerosis and other spinal cor...

Methods to produce rod-derived cone viability factor (RdCVF)

Gene therapy for amyotrophic lateral sclerosis and other spinal cor...

Purification of adenovirus and AAV

Purification of adenovirus and AAV

Tresyl-monomethoxypolyethylene glycol-modified viruses having viral...

Nucleic acid delivery vehicles

Chromatographic purification of adeno-associated virus (AAV)

Methods for purifying cystic fibrosis transmembrane conductance reg...

Patents Applicationslast 30 patents

VARIANT RNAi

ANALYTICAL ULTRACENTRIFUGATION FOR CHARACTERIZATION OF RECOMBINANT...

ANALYTICAL ULTRACENTRIFUGATION FOR CHARACTERIZATION OF RECOMBINANT...

Compositions and Methods for Treating Spinal Muscular Atrophy

TARGETED GENE THERAPY FOR DM-1 MYOTONIC DYSTROPHY

GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL COR...

METHODS TO PRODUCE ROD-DERIVED CONE VIABILITY FACTOR (RDCVF)

ANALYTICAL ULTRACENTRIFUGATION FOR CHARACTERIZATION OF RECOMBINANT...

GENE THERAPY FOR RETINITIS PIGMENTOSA

MODIFIED ADENO-ASSOCIATED VIRAL CAPSID PROTEINS FOR OCULAR GENE THE...

COMPOSITIONS AND METHODS FOR TREATING SPINAL MUSCULAR ATROPHY

VARIANT RNAi

METHODS FOR DETECTING AAV

GENE THERAPY FOR SPINAL CORD DISORDERS

ANALYTICAL ULTRACENTRIFUGATION FOR CHARACTERIZATION OF RECOMBINANT...

VARIANT RNAi

VARIANT RNAi

GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL COR...

GENE THERAPY FOR RETINITIS PIGMENTOSA

METHODS TO PRODUCE ROD-DERIVED CONE VIABILITY FACTOR (RDCVF)

GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL COR...

ANALYTICAL ULTRACENTRIFUGATION FOR CHARACTERIZATION OF RECOMBINANT...

VARIANT RNAi

METHODS TO PRODUCE ROD-DERIVED CONE VIABILITY FACTOR (RDCVF)

GENE THERAPY FOR RETINITIS PIGMENTOSA

COMPOSITIONS AND METHODS FOR TREATING SPINAL MUSCULAR ATROPHY

GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL COR...

METHODS TO PRODUCE ROD-DERIVED CONE VIABILITY FACTOR (RDCVF)

PURIFICATION OF ADENOVIRUS AND AAV

GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL COR...